SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Roshan Hanif A

(Last)

(First)

(Middle)

AEON GLOBAL HEALTH CORP.

2225 CENTENNIAL DR.

(Street)

GAINESVILLE

30504

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Aeon Global Health Corp. [ AGHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

3. Date of Earliest Transaction (Month/Day/Year)
07/19/2018

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Convertible Note⁽¹⁾	$1.2	07/19/2018		D⁽¹⁾			$255,417	03/20/2017⁽¹⁾	03/20/2019⁽¹⁾	Common Stock	212,847	$0	0	D
Convertible Note⁽¹⁾	$1.2	07/19/2018		D⁽¹⁾			$504,452	03/27/2018⁽¹⁾	03/20/2019⁽¹⁾	Common Stock	420,376	$0	0	D
Restricted Stock Rights⁽²⁾	⁽²⁾	07/19/2018		A		911,500		⁽²⁾	⁽²⁾	Common Stock	911,500	$0⁽²⁾	911,500	D

Explanation of Responses:

1. Effective on July 19, 2018 the registrant entered into a transaction with the reporting person to exchange (i) a preexisting note originally issued to the reporting person on March 20, 2017 and amended on March 27, 2018 in the aggregate principal amount of $255,417 and (ii) a preexisting note originally issued to the reporting person on March 27, 2018 in the aggregate principal amount of $504,452 for a new secured note for a maximum principal amount of $1,100,000 (the "New Note"). The New Note is not convertible into any equity securities of the registrant. The preexisting notes held by the reporting person were deemed cancelled upon the issuance of the New Note pursuant to such exchange transaction.

2. Represents the right to receive 911,500 shares of common stock on February 28, 2019 pursuant to the terms of a Settlement and Restructuring Agreement dated July 19, 2018 (the "Settlement Agreement") among the reporting person, the registrant and certain other parties named therein. The shares issuable under the Settlement Agreement will be deemed earned and issued on February 28, 2019.

	/s/ Hanif A. Roshan	07/23/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.